Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial.
about
Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's diseaseEffect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled TrialsWorking memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer's diseaseω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussionDietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerizationN-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for PsychopathologyOmega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's DiseaseOmega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.The role of nutrition on cognition and brain health in ageing: a targeted approach.Effects of Long-Chain Omega-3 Polyunsaturated Fatty Acids on Endothelial Vasodilator Function and Cognition-Are They Interrelated?Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials.ω-3 fatty acids in the prevention of cognitive decline in humans.The role for dietary omega-3 fatty acids supplementation in older adults.Omega-3 supplementation and loneliness-related memory problems: secondary analyses of a randomized controlled trial.Docosahexaenoic acid and adult memory: a systematic review and meta-analysisLong-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA.Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials.Understanding the gastrointestinal tract of the elderly to develop dietary solutions that prevent malnutrition.Recommendations on screening for cognitive impairment in older adultsDHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older Adults.Association of fish oil supplement use with preservation of brain volume and cognitive functionExercise and DHA prevent the negative effects of hypoxia on EEG and nerve conduction velocity.The n-3 Polyunsaturated Fatty Acids Supplementation Improved the Cognitive Function in the Chinese Elderly with Mild Cognitive Impairment: A Double-Blind Randomized Controlled Trial.Criteria for validation and selection of cognitive tests for investigating the effects of foods and nutrients.Treatment for mild cognitive impairment: a systematic review and meta-analysisDietary DHA and health: cognitive function ageing.Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease.Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.Association of dietary intake and lifestyle pattern with mild cognitive impairment in the elderly.DHA and improvement of memory function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006V0137 and ‘a reduced loss of cognitive function’: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials.Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function.Genetic Variants of the FADS Gene Cluster Are Associated with Erythrocyte Membrane LC PUFA Levels in Patients with Mild Cognitive Impairment.Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes.Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?Nutrient biomarkers and vascular risk factors in subtypes of mild cognitive impairment: a cross-sectional study.Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant Women: An Analysis of NHANES 2001-2014.
P2860
Q26766462-C030FD14-24D3-45C3-BA82-850A36533C0FQ26770351-DCB6CB5A-D77F-4DA2-9AB1-E6D82E66862EQ26778406-9D53C175-14AC-4B44-A300-374E2E287251Q26991937-5595AB96-B1C4-4DCE-A05D-43CE92EE76E2Q27307991-8829CCDF-5253-4A89-911A-AEE2C42548FFQ28072641-A2ED746C-0C20-433B-83C0-E48C0FF424BDQ28080464-2BD5D525-9EAA-4978-81F7-556874BCF14CQ30101111-F0ABA91F-1A17-4757-ACA6-01FB83D22205Q30238885-149A813F-305A-481F-A244-E322051521D2Q30779251-F538EB89-F4E5-4BFE-BB58-44FAD3F9F94DQ31031167-199DAB47-7DA2-436B-9895-5A3CE8F8F382Q33749456-C1519C2B-2BF9-4BF7-AC53-8A397FC9DEDCQ33963305-80538749-AE31-4E76-9F61-41AA1638E31EQ34384913-3FF80C8E-0599-4A82-8E09-E1639197B55DQ34411620-D685CF1B-37B6-418E-9F48-D2D966F36328Q34890890-360258A2-E927-4578-9AA7-BF25711B5C90Q35192515-D17C0C62-2BF3-413D-A8B3-0C2297CF1130Q35507433-46D98429-E6A7-43F5-8310-BF5C425565A2Q35646725-9ACE0DFF-1B37-4681-A69C-46D09BC7D35DQ35668855-22AD86A8-0978-4610-A12B-242DB9CC13A1Q36415027-0219944A-7339-44AB-804E-61868BE16206Q36633305-DC17B31F-F9CC-44F4-881D-76840B0F2D9AQ36791964-66153FC2-AF24-44D5-B417-9F7602CD23BDQ37430636-7D1E808A-42BD-4AED-96BC-CDE290AC512BQ37628428-42737CED-2C6D-47E0-9CAA-872ECA0DBAB9Q38201766-5AF0106D-6E1F-4B59-B5CC-A8B404A719ECQ38697692-21DFF290-A5FF-44C1-840B-256660C9598AQ39014590-6BA59AD5-106E-4C90-AA22-901179852246Q39928314-055D01D3-FFEE-4433-830E-9E96D1088D4BQ40902386-82CE7681-EFD5-449C-A3CD-C6940B9F6FD9Q41479749-7C1630FC-4F77-4F06-A9F6-88B60617747EQ47157765-5224519D-6CA4-4D1D-B1A3-9F7D03603C61Q47158010-2C53AD17-432C-4B9E-B2F0-9C5CF6C8DE85Q47309976-7FA84949-2C0A-435A-AFBA-3DFB402A17FBQ47967901-E2705D40-252F-473D-A01C-5455D64C7A39Q48052927-AE96967D-C0A9-4F44-A5B0-9F9978DE8D89Q48065222-B14AE3AD-1010-4784-95F3-CD710B29ADBAQ49885017-0EDC0F0C-3712-487E-BE20-0F32A7C9A385Q50609652-15B457DB-2561-4BE0-B59C-7DBB4C32E299Q53076572-A5E88B67-B881-4FCC-AB47-C9DA4D955210
P2860
Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Docosahexaenoic acid-concentra ...... ind, placebo-controlled trial.
@en
Docosahexaenoic acid-concentra ...... ind, placebo-controlled trial.
@nl
type
label
Docosahexaenoic acid-concentra ...... ind, placebo-controlled trial.
@en
Docosahexaenoic acid-concentra ...... ind, placebo-controlled trial.
@nl
prefLabel
Docosahexaenoic acid-concentra ...... ind, placebo-controlled trial.
@en
Docosahexaenoic acid-concentra ...... ind, placebo-controlled trial.
@nl
P2860
P1433
P1476
Docosahexaenoic acid-concentra ...... lind, placebo-controlled trial
@en
P2093
Noor Aini Mohd Yusoff
Suzana Shahar
P2860
P2888
P304
P356
10.1007/S00213-012-2848-0
P577
2012-08-30T00:00:00Z